Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21

Diana Ronai Dunshee1, Travis W Bainbridge2, Noelyn M Kljavin3

  • 1From Molecular Biology.

Insights

Fibroblast activation protein (FAP) inactivates the hormone FGF21. Inhibiting FAP stabilizes FGF21, offering a potential therapy for metabolic disorders like obesity and type 2 diabetes.

Area of Science:

  • Endocrinology
  • Metabolic disease research
  • Enzymology

Background:

  • Fibroblast activation protein (FAP) is an enzyme implicated in various physiological and pathological processes.
  • Fibroblast Growth Factor 21 (FGF21) is a hormone known for its metabolic benefits, including anti-obesity and insulin-sensitizing effects.
  • The endogenous regulation and degradation pathways of FGF21 are not fully elucidated.

Purpose of the Study:

  • To identify the specific enzyme responsible for the proteolytic cleavage and inactivation of endogenously produced human FGF21.
  • To investigate the potential of targeting this enzyme for therapeutic intervention in metabolic diseases.

Main Methods:

  • Utilized biochemical assays to identify the protease cleaving human FGF21.
  • Employed a selective chemical inhibitor of FAP, FAP immunodepletion, and genetic deletion of Fap to assess its effect on FGF21 stability.
  • Administered a selective FAP inhibitor to cynomolgus monkeys to measure changes in circulating intact FGF21 levels.

Main Results:

  • Identified fibroblast activation protein (FAP) as the primary enzyme that cleaves and inactivates human FGF21.
  • Demonstrated that FAP inhibition (chemical, immunologic, or genetic) stabilizes recombinant human FGF21 in serum.
  • Showed that acute administration of a selective FAP inhibitor increases circulating intact FGF21 levels in non-human primates.

Conclusions:

  • Fibroblast activation protein (FAP) plays a key role in the degradation of FGF21.
  • Selective FAP inhibition represents a promising therapeutic strategy to enhance endogenous FGF21 activity.
  • This approach holds potential for treating metabolic disorders such as obesity, type 2 diabetes, and non-alcoholic steatohepatitis.

Related Concept Videos

Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
4.3K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
Actin Filament Depolymerization01:19

Actin Filament Depolymerization

Actin filaments (F-actin) are composed of actin subunits. The dissociation of actin monomers can occur from either end of F-actin. The rate of dissociation is faster from the minus-end or the pointed end, where the actin subunits exist with a bound ADP, together known as ADP-actin. The depolymerization of F-actin is aided by proteins, including the actin-depolymerizing factor (ADF) and cofilin family of proteins, gelsolin, and glia maturation factor (GMF).
In F-actin, the ADF/cofilin proteins...
4.2K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.2K